Verification of Benefits and Utilization Review as Revenue Protection in Addiction Treatment: The Admission Gate, the Expected Reimbursement Before the Bed Is Filled, the Continued-Stay Review Cadence, the Appeal Economics, Out-of-Network Realities, and the Cash Cycle That Runs Past Sixty Days

A therapy group bills a session after it happens and learns within weeks whether it was paid. A residential or intensive outpatient program commits a bed, a staff ratio, and a daily cost to a client for weeks at a time, and learns whether it will be paid in blocks — at admission, at each continued-stay review, and at final adjudication sixty days later. The two functions that protect that revenue are verification of benefits before admission and utilization review during the stay, and in most programs both are run as clinical-administrative tasks rather than as the finance functions they are.

What should verification of benefits confirm before admission?

Verification of benefits is a financial decision disguised as a phone call. Before admission is accepted, the program confirms active coverage; whether the level of care — detox, residential, partial hospitalization, intensive outpatient — is a covered benefit under the plan and whether the facility's type and licensure qualify; in-network or out-of-network status for this facility; the deductible remaining, coinsurance, and out-of-pocket maximum; whether prior authorization is required and the criteria the payer applies; any benefit-year day limits; and the plan's history of continued-stay denials at this level of care, which the program knows from its own remittance data by payer.

The output is an expected reimbursement per admission, not a yes. From the verification, the admissions coordinator and the finance function produce a number: expected net revenue for the episode — authorized days times the per-diem rate (or the out-of-network reimbursement reality), less the continued-stay denial probability for this payer, less the patient-responsibility amount and its collection probability — and the expected cost of the episode at the program's cost per client day. An admission with a US$14,000 expected net on a US$17,000 expected cost is a decision the owners should make knowingly, by mission or by exception, not one that happens because a bed was open.

Patient responsibility is collected or arranged at admission. The deductible and coinsurance amounts verified before admission are collected, deposited, or placed on a documented payment plan before the client is admitted; programs that admit first and bill later collect a fraction of patient responsibility in this segment, where clients and families are in crisis at admission and gone at discharge.

The admission-gate metrics. Share of admissions with complete verification before admission (target above 95 percent); share with expected reimbursement computed and reviewed; share admitted below expected cost, and by whose decision; patient-responsibility collected at admission as a share of amounts verified.

How should authorizations and continued-stay reviews be managed?

Authorization arrives in blocks and expires. Initial authorization for residential is commonly three to seven days; continued-stay reviews follow at intervals the payer sets, against medical-necessity criteria that are the payer's own or a published standard; a day delivered after an authorization lapses, or beyond the days approved, is unbillable regardless of clinical appropriateness. The utilization-review function tracks every client's authorized days, used days, next review date, and the documentation the next review requires — and the clinical team documents to criteria from day one, because a review lost on documentation is revenue lost on paper.

The review cadence is a calendar with revenue attached. A tracker by client: payer, level of care, authorization start and end, days remaining, review due date and time, the reviewer assigned, the criteria elements the payer weighs, and the clinical documentation status against each element; reviews are prepared the day before and submitted the day they are due; a late review is a gap day, and gap days are the most common source of unbillable days in programs that measure them.

Continued-stay denials, by payer and reason. Denied for not meeting criteria at this level of care (the payer wants a step-down); denied for insufficient documentation; denied for administrative reasons (late submission, missing elements); approved at a lower level of care than requested. Each reason has a different remedy — clinical, documentation, or process — and the denial rate by payer by reason is the utilization-review function's scorecard.

When is an appeal worth filing?

An appeal is a priced decision. Expedited peer-to-peer appeals, written appeals within the payer's window, and external review where state law provides it — each costs clinical and administrative hours, and each has an overturn probability the program knows from its own history by payer. A continued-stay denial on three days at US$720 a day is US$2,160 of revenue; a peer-to-peer that takes a clinician ninety minutes and overturns 55 percent of the time for this payer is worth about US$1,190 in expected value against roughly US$200 of cost. The program appeals what pays and tracks what it does not.

The appeal file. Denials by payer and reason; appeals filed, by type; overturn rate by payer and type; hours spent; revenue recovered; and the denials not appealed with the reason — because a program that appeals a third of its appealable denials is writing off the other two-thirds by default.

What does out-of-network billing actually pay?

Out-of-network billing is a different revenue model with its own arithmetic. Billed charges are not expected revenue; the payer's allowed amount — set by a percentage of a fee schedule or a usual-and-customary database — is, and the difference is either balance-billed to the client within what state law permits or written off; patient responsibility is larger and less collectible; payment timing is slower; and payers' out-of-network reimbursement policies have tightened materially in many markets. The finance function computes expected out-of-network net per client day from remittance history, not from the chargemaster, and the admission gate uses that number.

The in-network transition decision. Modeled, not assumed: net per client day in-network at the contracted rate against out-of-network reality, volume effects of network inclusion, authorization burden differences, and collection of patient responsibility under each — a decision many programs are making in stages, payer by payer.

How long does cash take to arrive in addiction treatment?

Days to cash in this segment routinely exceed sixty. Per-diem claims submitted after authorization blocks or at discharge, payer review, appeals in flight, and patient responsibility on payment plans — against payroll every two weeks and a facility cost every month; the 13-week cash forecast is built by payer with these lags, and the working-capital facility is sized to a receivables cycle of sixty to ninety days, not to a round number. A program with US$9 million of annual revenue and a 70-day cycle carries about US$1.7 million of receivables as a matter of structure.

Receivables carried at face value is the finding that most often surprises owners. The allowance for uncollectible receivables — by payer and age, from the program's own collection history, including the out-of-network allowed-amount reality and patient-responsibility recovery — is routinely absent, and the first accrual close restates the balance sheet by a meaningful amount.

How should utilization review be staffed?

Utilization review is clinical staff with a revenue mandate. A licensed clinician or nurse with training in the payers' criteria, caseloads of 25 to 40 clients in review depending on level of care and payer mix, time blocked for reviews and peer-to-peers, and a performance scorecard: gap days, denial rate by payer, overturn rate, revenue protected. A 24-bed residential program with a partial hospitalization step-down typically needs one full-time reviewer and backup; the role pays for itself many times over, which is why it is budgeted as revenue protection and not as administrative overhead.

Verification is admissions staff with a finance output. Trained on payer benefit structures and the program's expected-reimbursement model, with a checklist that produces the number before the bed is offered.

Why is this CFO work?

The expected-reimbursement model is built from remittance data by payer; the appeal economics are a cost-benefit calculation; the out-of-network net per day is measured, not quoted; the cash cycle and the allowance are balance-sheet work; and the scorecards for both functions are finance deliverables that make a clinical process accountable for the revenue it protects. The clinical team documents and reviews; the CFO builds the gate, the tracker, and the numbers.

Worked example

A 24-bed residential program with a 20-slot partial hospitalization step-down, US$9.4 million annual revenue, mixed in-network and out-of-network, one part-time utilization reviewer shared with case management.

Illustrative figures for a hypothetical organization; not a client's data.

The plan: a verification gate with the expected-reimbursement model, and an admissions committee rule for any admission below expected cost; patient-responsibility collection or documented plan at admission; a full-time utilization reviewer with a day-before review protocol and a documentation-to-criteria template for the clinical team; an appeal protocol with payer-specific expected values; out-of-network net from remittance data in every admission decision and an in-network analysis for the two largest out-of-network payers; an allowance of US$260,000 recorded; and a working-capital line sized to a 70-day cycle. Modeled first-year effect: gap days to under 1 percent (≈ US$140,000), denial rate on the largest payer to 9 percent (≈ US$290,000 of protected episode revenue), patient-responsibility collection to 80 percent (≈ US$190,000), and admissions-below-cost reduced by half (≈ US$200,000) — roughly US$820,000 against a reviewer, an admissions coordinator, and training.